Ultrasound-enabled targeting of specific brain circuits

The combination of focused ultrasound and virally encoded receptors engineered to be activated by a designer drug enables, on intravenous administration of the drug, the non-invasive activation or inhibition of brain regions in mice, with cell-type and spatiotemporal specificity.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Go to the profile of Pep Pàmies
over 7 years ago

The cover illustrates the non-invasive modulation of brain circuits, with cell-type and spatiotemporal specificity, via focused ultrasound and virally encoded receptors engineered to be activated by a designer drug.

See Szablowski et al., https://doi.org/10.1038/s41551-018-0258-2 

Image: Maayan Harel and Jerzy Szablowski. Cover design: Alex Wing.

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With Collections, you can get published faster and increase your visibility.

Implantable wireless communication technologies

This collection brings together research that addresses critical engineering challenges in implantable wireless communications. It demonstrates how electromagnetic, optical, acoustic, or hybrid methods can be engineered to achieve reliable wireless communications and power delivery through biological tissues.

Publishing Model: Hybrid

Deadline: Nov 28, 2026

Biosensing

With this cross-journal Collection, the editors of Communications Biology, Nature Biomedical Engineering, Nature Sensors, Nature Communications, and Scientific Reports welcome the submission of primary research Articles focusing on the development of engineered biosensing devices with the potential to be applied in biomedical research and in the management of disease conditions.

Publishing Model: Hybrid

Deadline: Jun 30, 2026